Annie Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annie Xiong has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cathryn Sibbald
Division of Dermatology, Department of Medicine University of Toronto Toronto Ontario Canada
1 shared publication David Croitoru
Division of Dermatology, Department of Medicine University of Toronto Toronto Ontario Canada
1 shared publicationErfan Ghani Kakhki
Michael G. DeGroote School of Medicine McMaster University Hamilton Ontario Canada
1 shared publication- Grace Xiong
Michael G. DeGroote School of Medicine McMaster University Hamilton Ontario Canada
1 shared publication - Ilya Mukovozov
Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada
1 shared publication Mohamed Ali
Michael G. DeGroote School of Medicine McMaster University Hamilton Ontario Canada
1 shared publication
Latest Publications
- Open Access
- 4 September 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (6) , 1142-1148
Prevalence, Age of Onset, Age at Diagnosis, and Family History of Hidradenitis Suppurativa in Pediatric Populations: A Systematic Review and Meta‐Analysis
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses in intertriginous areas, ultimately resulting in scarring and formation of sinus tracts. HS significantly impacts quality of life and can also affect pediatric populations. We aimed to determine the prevalence, family history, age of onset, and age at diagnosis of HS in pediatric populations. Methods: A random‐effects meta‐analysis of observational studies was conducted following MOOSE guidelines. Five databases were searched through May 2024. Results: Thirty seven observational studies were included, representing 6941 patients from 13 countries. The weighted mean age was 14.7 years (range: 4–18). Ethnoracial distribution included White (36.5%), Black (38.3%), Hispanic (13.9%), Asian (0.8%), Indigenous (0.2%), Middle Eastern (0.7%), multiracial (1.2%), and unspecified populations (8.4%). Among studies reporting severity, 42.5% had Hurley Stage I, 46.3% Stage II, and 11.2% Stage III. The prevalence of HS in pediatric populations was 0.03% (95% CI [0.0001, 0.0005]), with 38% of patients having a family history of HS (95% CI [0.30, 0.45]). Pediatric‐onset HS predominantly affects females (78%, 95% CI [0.76, 0.80]). The average age of onset of HS in pediatric populations was 11.3 years (95% CI [10.15, 12.39]), but diagnosis typically occurred at 14.0 years (95% CI [12.65, 15.28]), indicating a delay in diagnosis. Female predominance of HS was associated with earlier age of onset and age at diagnosis, while no significant correlations between family history, age of onset, or age at diagnosis were identified. Conclusion: This study highlights the characteristics of pediatric‐onset HS and emphasizes the need for earlier detection to expedite diagnosis and initiation of treatment.
- 4 September 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (6) , 1142-1148
Open AccessPrevalence, Age of Onset, Age at Diagnosis, and Family History of Hidradenitis Suppurativa in Pediatric Populations: A Systematic Review and Meta‐Analysis
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses in intertriginous areas, ultimately resulting in scarring and formation of sinus tracts. HS significantly impacts quality of life and can also affect pediatric populations. We aimed to determine the prevalence, family history, age of onset, and age at diagnosis of HS in pediatric populations. Methods: A random‐effects meta‐analysis of observational studies was conducted following MOOSE guidelines. Five databases were searched through May 2024. Results: Thirty seven observational studies were included, representing 6941 patients from 13 countries. The weighted mean age was 14.7 years (range: 4–18). Ethnoracial distribution included White (36.5%), Black (38.3%), Hispanic (13.9%), Asian (0.8%), Indigenous (0.2%), Middle Eastern (0.7%), multiracial (1.2%), and unspecified populations (8.4%). Among studies reporting severity, 42.5% had Hurley Stage I, 46.3% Stage II, and 11.2% Stage III. The prevalence of HS in pediatric populations was 0.03% (95% CI [0.0001, 0.0005]), with 38% of patients having a family history of HS (95% CI [0.30, 0.45]). Pediatric‐onset HS predominantly affects females (78%, 95% CI [0.76, 0.80]). The average age of onset of HS in pediatric populations was 11.3 years (95% CI [10.15, 12.39]), but diagnosis typically occurred at 14.0 years (95% CI [12.65, 15.28]), indicating a delay in diagnosis. Female predominance of HS was associated with earlier age of onset and age at diagnosis, while no significant correlations between family history, age of onset, or age at diagnosis were identified. Conclusion: This study highlights the characteristics of pediatric‐onset HS and emphasizes the need for earlier detection to expedite diagnosis and initiation of treatment.